| Literature DB >> 34284733 |
Galit Yogev-Seligmann1, Michal Kafri2.
Abstract
BACKGROUND: The purpose of this study was to describe the effects of COVID-19 social distancing on the function, health, and well-being of people with Parkinson disease (PD), and test the association of these effects with patients' activation levels, i.e., their skills and confidence in managing their health.Entities:
Keywords: COVID-19; Parkinson disease; Patient activation; Self-management; Social distancing
Year: 2021 PMID: 34284733 PMCID: PMC8289714 DOI: 10.1186/s12883-021-02313-6
Source DB: PubMed Journal: BMC Neurol ISSN: 1471-2377 Impact factor: 2.474
Respondents’ functional characteristics according to survey questions 1, 2, and 4
| Survey question | Response | Response rate (%) |
|---|---|---|
| Walking independently | 65.2% | |
| Using cane or walker | 31.9% | |
| Using wheelchair | 2.8% | |
| Walk independently | 71.4% | |
| Require another person's supervision | 20.0% | |
| Require another person's physical support and help | 8.6% | |
| Independent in all daily functions | 63.4% | |
| Require supervision in some or all of my daily functions | 14.1% | |
| Require a little help in some or all of my daily functions | 18.3% | |
| Require medium to great help in some or all of my daily functions | 4.2% |
Fig. 1Effects of social distancing and lockdown on function, health, medical care and well-being. Bars represent the percentage of participants who reported a change in each of the domains during the lockdown period relative to the previous period
Association of patient activation measure level with effects of social distancing and the lockdown
| Association with PAM-13 level (Spearman’s rank) | Variable |
|---|---|
| -0.23 ( | Increased assistance with ADL |
| -0.26 ( | Worsening of disease symptoms |
| -0.31 ( | Increased tiredness |
| -0.33 ( | Lack of family members’ and friends’ support |
ADL activities of daily living, PAM Patient Activation Measure
Proportion of low and high activation level respondents with reported change in measured PAM-13 domains
| Patient’s activation level | χ2(DF), p | |||
|---|---|---|---|---|
| Low level of activation (PAM-13 levels 1 and 2, | High level of activation | |||
| Increased assistance with ADL | No | 58.7% | 83.2% | χ2 (1) = 9.94, |
| Yes | 41.3% | 16.8% | ||
| Worsening of disease symptoms | No | 40% | 63.8% | χ2 (1) = 7.02, |
| Yes | 60% | 36.2% | ||
| Increased tiredness | No | 33.3% | 67% | χ2 (1) = 14.02 |
| Yes | 66.7% | 33% | ||
| Lack of family members’ and friends’ support | No | 30.4% | 63.5% | χ2 (1) = 13.68 |
| Yes | 69.6% | 36.5% | ||
ADL activities of daily living, PAM Patient Activation Measure